C. Thivolet

C. Thivolet, E. Morelon, L. Badet, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus.

E. Disse, C. Thivolet, O. Dupuis, 2013, Diabetes & metabolism.

Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration.

D. Maucort-Boulch, C. Thivolet, J. Vouillarmet, 2013, Diabetes technology & therapeutics.

Protection Against Autoimmune Diabetes With Oral Insulin Is Associated With the Presence of IL-4 Type 2 T-Cells in the Pancreas and Pancreatic lymph Nodes

C. Thivolet, N. Fabien, C. Ploix, 1998, Diabetes.

Hibernoma and multiple endocrine neoplasia type 1 syndrome: A non-fortuitous association? A case report and literature review.

F. Cotton, C. Thivolet, S. Giraud, 2017, Annales d'endocrinologie.

Increased TSH in obesity: Evidence for a BMI-independent association with leptin.

E. Disse, M. Laville, J. Drai, 2015, Diabetes & metabolism.

[ Absence of evidence of a possible connection vaccination for hepatitis B and the development of diabetes type 1. Report of a group of ALFEDIAM experts].

J. Bringer, C. Boitard, C. Thivolet, 1999, Diabetes & metabolism.

Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon

J. Rieusset, S. Ducreux, F. van Coppenolle, 2016, PloS one.

Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway

J. Rieusset, D. Bosco, S. Ducreux, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Normal reproductive function in leptin-deficient patients with lipoatropic diabetes.

M. Laville, F. Andreelli, J. Riou, 2000, The Journal of clinical endocrinology and metabolism.

Beta cells in type 1 diabetes: victims or activators of t cell response?

C. Thivolet, 2002, Diabetes & metabolism.

New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies

C. Thivolet, 2001, Clinical endocrinology.

Perspectives in early detection and management of IDDM

C. Thivolet, 2000 .

Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation.

C. Thivolet, J. Dubernard, P. Petruzzo, 2000, Transplantation.

Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes.

D. Lombardo, C. Thivolet, E. Mas, 1999, Diabetes.

Liver adenomatosis in patients with hepatocyte nuclear factor‐1 alpha maturity onset diabetes of the young (HNF1A‐MODY): Clinical, radiological and pathological characteristics in a French series

P. Guillausseau, C. Bellanné-Chantelot, J. Wilhelm, 2019, Journal of diabetes.

Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?

E. Disse, J. Drai, C. Thivolet, 2015, Diabetes & metabolism.

Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice.

V. Maguer-Satta, C. Thivolet, J. Orgiazzi, 1995, Journal of autoimmunity.

Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

C. Thivolet, J. Stanley, L. Koulu, 1984, The Journal of clinical investigation.

Predictive Factors of Type 2 Diabetes Remission 1 Year After Bariatric Surgery: Impact of Surgical Techniques

E. Disse, M. Robert, M. Laville, 2013, Obesity Surgery.

Interference of Elevated Fetal Hemoglobin on HbA1c Measurements in Adult Type I Diabetic Patient

C. Thivolet, V. Vassy, A. Revol, 1991, Diabetes Care.

Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11

H. Kolb, W. Scherbaum, C. Thivolet, 2016, Diabetes Care.

Insulin‐like growth factor‐1 (IGF‐1) protects NOD mice from insulitis and diabetes

C. Thivolet, N. Fabien, I. Bergerot, 1995, Clinical and experimental immunology.

Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network

E. Renard, T. Berney, J. Bosson, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000)

F. Ris, P. Morel, J. Oberholzer, 2001, Diabetologia.

Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.

W. Scherbaum, C. Thivolet, J. Endl, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Nasal administration of CTB‐insulin induces active tolerance against autoimmune diabetes in non‐obese diabetic (NOD) mice

C. Aspord, C. Thivolet, 2002, Clinical and experimental immunology.

Structure, Function, and Immunogenicity of Human Insulinoma Cells

A. Demidem, C. Thivolet, M. Haftek, 1988, Diabetes.

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

C. Czerkinsky, J. Holmgren, C. Thivolet, 1999, Diabetes.

The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening.

E. Levy, P. Chatelain, F. Bienvenu, 2004, Pediatrics.

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

E. Disse, M. Laville, J. Drai, 2017, Diabetologia.

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

C. Vigouroux, E. Disse, M. Laville, 2019, Diabetes Care.

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response.

P. Saintigny, C. Thivolet, N. Fabien, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative

A. Vambergue, S. Hadjadj, B. Balkau, 2022, Diabetologia.

Morphological and functional effects of extracellular matrix on pancreatic islet cell cultures.

C. Thivolet, P. Chatelain, A. Durand, 1985, Experimental cell research.

Autoimmune polyendocrine failure — Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism — after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia

F. Birg, C. Thivolet, B. Vialettes, 1993, Diabetologia.

The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies

Å. Lernmark, A. Ziegler, S. Nagataki, 1991, Diabetologia.

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

C. Boitard, B. Charbonnel, P. Bougnères, 2000, Lancet.

Reduction of endoplasmic reticulum- mitochondria interactions in beta cells from patients with type 2 diabetes

J. Rieusset, A. Madec, C. Thivolet, 2017, PloS one.

Pancreas retransplantation: a second chance for diabetic patients?

T. Berney, C. Thivolet, E. Morelon, 2013, Transplantation.

Pancreas Retransplantation: A Second Chance for Diabetic Patients?

T. Berney, C. Thivolet, E. Morelon, 2013, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel.

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)

Ho Yee Cheung, James D. Clark, May Thin Khine, 2022, Cardiovascular Diabetology.

Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.

P. Moulin, C. Thivolet, N. Bendelac, 2018, Clinica chimica acta; international journal of clinical chemistry.

Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD).

C. Thivolet, J. Carel, I. Tardivel, 1995, Journal of autoimmunity.

The CXCR4/CXCL12 (SDF‐1) signalling pathway protects non‐obese diabetic mouse from autoimmune diabetes

A. Madec, C. Thivolet, E. Aboumrad, 2007, Clinical and experimental immunology.

alpha4 integrins and L-selectin differently orchestrate T-cell activity during diabetes prevention following oral administration of CTB-insulin.

C. Aspord, C. Czerkinsky, C. Thivolet, 2002, Journal of autoimmunity.

Autoantibodies and genetic factors associated with the development of Type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients

P. Chatelain, C. Thivolet, J. Orgiazzi, 1991, Diabetologia.

Islet cell and insulin autoantibodies in subjects at high risk for development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon family study

P. Chatelain, C. Thivolet, L. Gebuhrer, 1988, Diabetologia.

Carriage of Staphylococcus aureus and Local Infections in Diabetic Outpatients Treated With Insulin Pen

C. Thivolet, A. Mey, Y. Gille, 1990, Diabetes Care.

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.

John J. Shin, C. Thivolet, P. Choudhary, 2022, The lancet. Diabetes & endocrinology.

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study

S. Hadjadj, P. Gourdy, C. Thivolet, 2020, Diabetes Care.

Anti–Programmed Death 1 (PD-1) Antibodies and the Pancreas: A Diabetic Storm Ahead?

P. Saintigny, C. Thivolet, N. Fabien, 2018, Diabetes Care.

Lymphocyte Function Associated Antigen-1, Integrin α4, and L-Selectin Mediate T-Cell Homing to the Pancreas in the Model of Adoptive Transfer of Diabetes in NOD Mice

C. Thivolet, J. Orgiazzi, N. Fabien, 1996, Diabetes.

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study

S. Hadjadj, M. Marre, P. Gourdy, 2021, Diabetes Research and Clinical Practice.

Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE

H. Gin, M. Marre, C. Thivolet, 2009, Advances in therapy.

Impact of Anti–Insulin Antibodies on Islet Transplantation Outcome: Data From the GRAGIL Network

T. Berney, D. Bosco, L. Frimat, 2014, Transplantation.

Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse

E. Goillot, P. Bedossa, M. Bonnard, 1991, Diabetologia.

Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation.

F. Andreelli, C. Thivolet, J. Dubernard, 2000, Diabetes & metabolism.

Calcium-dependent low renin syndrome in a diabetic patient with prostaglandin deficiency

C. Thivolet, M. Vincent, F. Bonnet, 1998, Journal of endocrinological investigation.

Impact of the Number of Infusions on 2-Year Results of Islet-After-Kidney Transplantation in the GRAGIL Network

T. Berney, P. Morel, D. Bosco, 2011, Transplantation.

Active Suppression of Diabetes after Oral Administration of Insulin Is Determined by Antigen Dosage

C. Thivolet, N. Fabien, I. Bergerot, 1996, Annals of the New York Academy of Sciences.

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.

C. Thivolet, N. Fabien, I. Bergerot, 1994, Journal of autoimmunity.

Reversible Hyperkalemia at the Initiation of ACE Inhibitors in a Young Diabetic Patient With Latent Hyporeninemic Hypoaldosteronism

C. Thivolet, F. Bonnet, 1996, Diabetes Care.

Proliferative retinopathy with growth hormone deficiency and diabetes mellitus: Author's reply

C. Thivolet, 1990 .

No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial

G. Charpentier, E. Renard, P. Benhamou, 2021, Diabetes, obesity & metabolism.

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.

Pierre Jallon, Eric Renard, Maeva Doron, 2019, The Lancet. Digital health.

Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.

M. Zennaro, S. Boulkroun, C. Thivolet, 2016, The Journal of clinical endocrinology and metabolism.

Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study

L. Molinier, N. Costa, J. Buisson, 2022, Diabetes Therapy.

Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements.

J. Honnorat, P. Trouillas, C. Thivolet, 1995, Archives of neurology.

Serum reg protein level is not related to the beta cell destruction/regeneration process during early phases of diabetogenesis in type I diabetes.

C. Figarella, C. Thivolet, B. Vialettes, 1999, European journal of endocrinology.

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

S. Hadjadj, M. Marre, R. Roussel, 2020, Diabetes & Metabolism.

High-risk genotype for type 1 diabetes: a new simple microtiter plate-based ELOSA assay.

P. Leissner, B. Mougin, C. Thivolet, 2003, Genetic testing.

Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis

C. Auffray, M. Paye, B. Mougin, 2010, Genes and Immunity.

Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice

P. Bedossa, C. Thivolet, P. Edouard, 1993, European journal of immunology.

The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus.

A. Madec, C. Thivolet, J. Orgiazzi, 1999, The Journal of clinical endocrinology and metabolism.

Classification of diabetes in young adults: new concepts for an old disease.

C. Thivolet, C. Cugnet, 2005, Diabetes & metabolism.

Assessing diabetic foot osteomyelitis remission with white blood cell SPECT/CT imaging

C. Thivolet, J. Vouillarmet, I. Morelec, 2014, Diabetic medicine : a journal of the British Diabetic Association.

Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.

S. Rome, C. Thivolet, L. Marchand, 2015, Journal of molecular biomarkers & diagnosis.

Diabetes classification: grey zones, sound and smoke: Action LADA 1

A. de Leiva, H. Kolb, W. Scherbaum, 2008, Diabetes/metabolism research and reviews.

Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.

G M Lenoir, C Eng, C. Eng, 1997, American journal of human genetics.

GWAS-implicated in type 1 and type 2 diabetes loci: insight into their relative roles in the pathogenesis of Latent Autoimmune Diabetes in Adults (LADA)

H. Hakonarson, S. Grant, J. Bradfield, 2015 .

Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]

S. Hadjadj, R. Roussel, E. Cosson, 2020, Diabetologia.

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

S. Hadjadj, R. Roussel, E. Cosson, 2020, Diabetologia.

Diabetic Mastopathy: A frequent source of confusion with lobular breast carcinoma

C. Thivolet, Sylvie Rode, Claude Favre, 1998, Diabetes Care.

miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes

S. Rome, E. Meugnier, A. Madec, 2016, Journal of diabetes research.

Bilateral vertebral artery dissection revealing Cushing's syndrome.

C. Thivolet, J. Lifante, J. Vouillarmet, 2019, Annales d'endocrinologie.

Performance of the 4-mg intravenous dexamethasone suppression test in differentiating Cushing disease from pseudo-Cushing syndrome.

F. Borson‐Chazot, M. Rabilloud, C. Thivolet, 2016, Annales d'endocrinologie.

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: the SFDT1 study.

E. Vicaut, A. Bonnefond, R. Roussel, 2021, Diabetes & metabolism.

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype

A. de Leiva, J. Tuomilehto, H. Kolb, 2013, Diabetes Care.

Glucose inhibits angiogenesis of isolated human pancreatic islets.

T. Berney, A. Madec, A. Mesnier, 2010, Journal of molecular endocrinology.

Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.

C. Thivolet, C. Colin, F. Canouï-Poitrine, 2010, Diabetes & metabolism.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Multiple autoantibodies at onset do not accurately predict long-term pancreatic beta-cell fate in a 13-year-old obese child with immediate insulin-requiring diabetes.

C. Thivolet, B. Roep, M. Nicolino, 2016, Diabetes & metabolism.

Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens

G. Charpentier, E. Renard, A. Penfornis, 2012, Diabetes Care.

Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French Consortium GRAGIL.

P. Morel, J. Oberholzer, A. Penfornis, 2004, Diabetes care.

Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma [4]

C. Eng, G. Lenoir, M. Schlumberger, 1997 .

Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification.

D. Maucort-Boulch, C. Thivolet, B. Riche, 2017, Annales d'endocrinologie.

Interference of Dapsone in HbA1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica

C. Thivolet, A. Francina, A. Mayer, 1994, Diabetes Care.

Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography.

C. Thivolet, P. Denis, F. Aptel, 2008, Diabetes & metabolism.

Proliferative retinopathy in a woman with growth hormone deficiency and diabetes mellitus.

P. Chatelain, C. Thivolet, P. Fournier, 1990, British medical journal.

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3

D. Collier, A. de Leiva, D. Mauricio, 2009, Diabetes Care.

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports

M. Marre, C. Thivolet, A. Scheen, 2020, Diabetes & Metabolism.

Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes

E. Brugués, A. de Leiva, J. Tuomilehto, 2021, Diabetologia.

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.

H. Gin, M. Marre, C. Thivolet, 2009, Diabetes & metabolism.

Combined analysis of autoantibodies against beta-cells for prediction of pancreas allograft failure.

C. Thivolet, J. Dubernard, P. Petruzzo, 2000, Transplantation proceedings.

History of bariatric surgery and COVID‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

S. Hadjadj, F. Pattou, R. Roussel, 2021, Obesity.

Paramagnetic nanoparticles to track and quantify in vivo immune human therapeutic cells.

P. Perriat, O. Tillement, C. Aspord, 2013, Nanoscale.

[Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia].

D. Garrel, C. Thivolet, M. Pugeat, 1988, Presse medicale.

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

P Drouin, B Guerci, B. Charbonnel, 2003, Diabetes & metabolism.

Carotid atherosclerosis progression and cerebrovascular events in patients with diabetes.

D. Maucort-Boulch, C. Thivolet, B. Riche, 2016, Journal of diabetes and its complications.

Alpha cells, the main source of IL-1β in human pancreas.

M. V. von Herrath, C. Thivolet, Somayeh Sabouri, 2017, Journal of autoimmunity.

Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

T. Berney, D. Bosco, L. Frimat, 2015, Diabetes Care.

Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

E. Renard, T. Berney, P. Morel, 2009, Diabetic medicine : a journal of the British Diabetic Association.

Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals

W. Scherbaum, J. Petersen, P. Chatelain, 1992, Diabetologia.

Limits of clinical tests to screen autonomic function in diabetes type 1.

M. Ducher, C. Thivolet, C. Cerutti, 2001, Diabetes & metabolism.

Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting.

C. Thivolet, C. Telliam, 2020, Diabetes & metabolism.

Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37–43

C. Thivolet, C. Telliam, 2020, Diabetes Care.

Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

S. Hadjadj, R. Roussel, E. Cosson, 2020, Diabetologia.

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.

E. Renard, F. Pattou, T. Berney, 2018, The lancet. Diabetes & endocrinology.

Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol

F. Pattou, T. Berney, P. Benhamou, 2017, BMJ Open.

Diabetic Instability and Celiac Disease: A frequent association to keep in mind

F. Andreelli, J. Riou, C. Thivolet, 1998, Diabetes Care.

Measuring Vibration Sensations With Graduated Tuning Fork: Simple and Reliable Means to Detect Diabetic Patients at Risk of Neuropathic Foot Ulceration

C. Thivolet, J. Tourniaire, James El Farkh, 1990, Diabetes Care.

Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study

L. Molinier, N. Costa, J. Buisson, 2021, Diabetes Therapy.

Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?

A. Vambergue, C. Fagour, G. Charpentier, 2014, Diabetes & metabolism.

Oesophageal function assessed by high‐resolution manometry in patients with diabetes and inadequate glycaemic control

S. Roman, F. Mion, C. Thivolet, 2014, Diabetic medicine : a journal of the British Diabetic Association.

LOGISTICS AND TRANSPLANT COORDINATION ACTIVITY IN THE GRAGIL SWISS-FRENCH MULTICENTER NETWORK OF ISLET TRANSPLANTATION

T. Berney, P. Morel, L. Bühler, 2004, Transplantation.

Pancreas transplantation: results and indications.

C. Thivolet, J. Dubernard, N. Lefrançois, 1998, Diabetes & metabolism.

Real world evidence of the efficacy of two Hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings.

C. Thivolet, N. Bendelac, S. Villar Fimbel, 2022, Diabetes & metabolism.

Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study

A. Penfornis, C. Thivolet, B. Catargi, 2023, PloS one.

The 36% coefficient of variation for glucose proposed for separating stable and labile diabetes is clinically relevant: A continuous glucose monitoring-based study in a large population of type 1 diabetes patients.

E. Disse, C. Thivolet, J. Vouillarmet, 2019, Diabetes & metabolism.

Glycation of Hemoglobin C in the Heterozygous State in Diabetic Patients

C. Thivolet, R. Goujon, 1994, Diabetes Care.

Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?

C Cerutti, C Z Paultre, C. Thivolet, 1999, Diabetes care.

Diabetes classification: grey zones, sound and smoke: Action LADA 1

H. Kolb, W. Scherbaum, D. Hadden, 2008, Diabetes/metabolism research and reviews.

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

V. Rigalleau, P. Moulin, A. Penfornis, 2011, Trials.